During the past decade, New Mexico Cancer Care Alliance conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 14 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Mexico Cancer Care Alliance" #1 sponsor was "Novartis Pharmaceuticals" with 4 trials, followed by "Incyte Corporation" with 3 trials sponsored, "Alliance Foundation Trials, LLC." with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored and "NewLink Genetics Corporation" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Mexico Cancer Care Alliance" #1 collaborator was "GOG Foundation" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Breast Cancer Trials, Australia and New Zealand" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "New Mexico Cancer Care Alliance" are "Breast Cancer" (6 trials), "Acute Myeloid Leukemia" (3 trials), "Melanoma" (3 trials), "Metastatic Pancreatic Adenocarcinoma" (2 trials) and "Myelodysplastic Syndromes" (2 trials). Many other conditions were trialed in "New Mexico Cancer Care Alliance" in a lesser frequency.

Most popular intervention types in "New Mexico Cancer Care Alliance" are "Drug" (40 trials), "Biological" (5 trials), "Other" (4 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fulvestrant" (3 trials), "Gemcitabine" (3 trials), "Letrozole" (3 trials), "Cetuximab" (2 trials) and "Goserelin" (2 trials). Other intervention names were less common.

The vast majority of trials in "New Mexico Cancer Care Alliance" are 36 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "New Mexico Cancer Care Alliance". undefined are not yet recruiting, 4 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in New Mexico Cancer Care Alliance, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in New Mexico Cancer Care Alliance, 8 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".